Sunscreens, Photoimmunosuppression, and Photoaging

Clinical Guide to Sunscreens and Photoprotection

Volumn , Issue , 2008, Pages 101-116

  Halliday, Gary M ^a   Hönigsmann, Herbert ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Universitatsklinik fur Dermatologie   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84869205515     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9781420080858-11     Document Type: Chapter

References (103)

1. Halliday GM, Patel A, Hunt MJ, et al. Spontaneous regression of human melanoma/nonmelanoma skin cancer: Association with infiltrating CD4þ T cells. World J Surg 1995; 19(3): 352-358.
2. Lim HW, Naylor M, Honigsmann H, et al. American Academy of Dermatology consensus conference on UVA protection of sunscreens: Summary and recommendations. J Am Acad Dermatol 2001; 44(3): 505-508.
3. Stoitzner P, Tripp CH, Eberhart A, et al. Langerhans cells cross-present antigen derived from skin. Proc Natl Acad Sci U S A 2006; 103(20): 7783-7788.
4. Granstein RD, Matsui MS. UV radiation-induced immunosuppression and skin cancer. Cutis 2004; 74:4-9.
5. Cumberbatch M, Dearman RJ, Griffiths CEM, et al. Langerhans cell migration. Clin Exp Dermatol 2000; 25(5): 413-418.
6. Ebner S, Ehammer Z, Holzmann S, et al. Expression of C-type lectin receptors by subsets of dendritic cells in human skin. Int Immunol 2004; 16(6): 877-887.
7. Heath WR, Carbone FR. Cross-presentation, dendritic cells, tolerance and immunity. Ann Rev Immunol 2001; 19:47-64.
8. Kripke ML. Immunologic unresponsiveness induced by UV radiation. Immunol Rev 1984; 80:87-102.
9. Norval M. The effect of ultraviolet radiation on human viral infections. Photochem Photobiol 2006; 82(6): 1495-1504.
10. Kripke ML, Cox PA, Alas LG, et al. Pyrimidine dimers in DNA initiate systemic immunosuppression in UV-irradiated mice. Proc Natl Acad Sci U S A 1992; 89(16): 7516-7520.
11. Kuchel JM, Barnetson RS, Halliday GM. Cyclobutane pyrimidine dimer formation is a molecular trigger for solar-simulated ultraviolet radiation-induced suppression of memory immunity in humans. Photochem Photobiol Sci 2005; 4(8): 577-582.
12. Damian DL, Patterson CRS, Stapelberg M, et al. UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide. J Invest Dermatol 2008; 128:447-454.
13. Noonan FP, De Fabo EC. Immunosuppression by Ultraviolet B Radiation: Initiation by Urocanic Acid. Immunol Today 1992; 13(7): 250-254.
14. Norval M, Gibbs NK, Gilmour J. The role of urocanic acid in UV-induced immunosuppression-recent advances (1992-1994). Photochem Photobiol 1995; 62(2): 209-217.
15. Walterscheid JP, Nghiem DX, Kazimi N, et al. Cis-urocanic acid, a sunlight-induced immunosuppressive factor, activates immune suppression via the 5-HT2A receptor. Proc Natl Acad Sci U S A 2006; 103(46): 17420-17425.
16. Halliday GM. Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis. Mutat Res; Fundam Mol Mech Mutagen 2005; 571:107-120.
17. Rigas B, Sun Y. Induction of oxidative stress as a mechanism of action of chemopreventive agents against cancer. Br J Cancer 2008; 98(7): 1157-1160.
18. Kuchel JM, Barnetson RS, Halliday GM. Nitric oxide appears to be a mediator of solarsimulated ultraviolet radiation-induced immunosuppression in humans. J Invest Dermatol 2003; 121(3): 587-593.
19. Yuen KS, Halliday GM. Alpha-tocopherol, an inhibitor of epidermal lipid peroxidation, prevents ultraviolet radiation from suppressing the skin immune system. Photochem Photobiol 1997; 65(3): 587-592.
20. Yuen KS, Nearn MR, Halliday GM. Nitric oxide-mediated depletion of Langerhans cells from the epidermis may be involved in UVA radiation-induced immunosuppression. Nitric Oxide 2002; 6(3): 313-318.
21. Ullrich SE. Photoimmune suppression and photocarcinogenesis. Front Biosci 2002; 7:D684-D703.
22. Walterscheid JP, Ullrich SE, Nghiem DX. Platelet-activating factor, a molecular sensor for cellular damage, activates systemic immune suppression. J Exp Med 2002; 195(2): 171-179.
23. Bergstresser PR, Toews GB, Streilein JW. Natural and perturbed distributions of Langerhans cells: responses to ultraviolet light, heterotopic skin grafting, and dinitrofluorobenzene sensitization. J Invest Dermatol 1980; 75(1): 73-77.
24. Moodycliffe AM, Kimber I, Norval M. The effect of ultraviolet-B irradiation and urocanic acid isomers on dendritic cell migration. Immunology 1992; 77(3): 394-399.
25. Vink AA, Moodycliffe AM, Shreedhar V, et al. The inhibition of antigen-presenting activity of dendritic cells resulting from UV irradiation of murine skin is restored by in vitro photorepair of cyclobutane pyrimidine dimers. Proc Natl Acad Sci U S A 1997; 94(10): 5255-5260.
26. Byrne SN, Limon-Flores AY, Ullrich SE. Mast cell migration from the skin to the draining lymph nodes upon ultraviolet irradiation represents a key step in the induction of immune suppression. J Immunol 2008; 180(7): 4648-4655.
27. Hart PH, Grimbaldeston MA, Swift GJ, et al. Dermal mast cells determine susceptibility to ultraviolet B-induced systemic suppression of contact hypersensitivity responses in mice. J Exp Med 1998; 187(12): 2045-2053.
28. Hammerberg C, Duraiswamy N, Cooper KD. Active induction of unresponsiveness (tolerance) to DNFB by in vivo ultraviolet-exposed epidermal cells is dependent upon infiltrating class II MHC(þ) CD11b(bright) monocytic/macrophagic cells. J Immunol 1994; 153(11): 4915-4924.
29. Rana S, Byrne SN, Macdonald LJ, et al. Ultraviolet B suppresses immunity by inhibiting effector and memory T cells. Am J Pathol 2008; 172(4): 993-1004.
30. Schwarz T. 25 years of UV-induced immunosuppression mediated by T cells-from disregarded T suppressor cells to highly respected regulatory T cells. Photochem Photobiol 2008; 84(1): 10-18.
31. Byrne SN, Halliday GM. B cells activated in lymph nodes in response to ultraviolet irradiation or by interleukin-10 inhibit dendritic cell induction of immunity. J Invest Dermatol 2005; 124(3): 570-578.
32. Kelly DA, Young AR, McGregor JM, et al. Sensitivity to sunburn is associated with susceptibility to ultraviolet radiation-induced suppression of cutaneous cell-mediated immunity. J Exp Med 2000; 191(3): 561-566.
33. Damian DL, Barnetson RS, Halliday GM. Low-dose UVA and UVB have different time courses for suppression of contact hypersensitivity to a recall antigen in humans. J Invest Dermatol 1999; 112(6): 939-944.
34. Poon TSC, Barnetson RSC, Halliday GM. Sunlight-induced immunosuppression in humans is initially because of UVB, then UVA, followed by interactive effects. J Invest Dermatol 2005; 125(4): 840-846.
35. Yaar M, Gilchrest BA. Photoageing: mechanism, prevention and therapy. Br J Dermatol 2007; 157(5): 874-887.
36. Fisher GJ, Varani J, Voorhees JJ. Looking older. Fibroblast collapse and therapeutic implications. Arch Dermatol 2008; 144:666-672.
37. Yarosh D, Dong K, Smiles K. UV-induced degradation of collagen I is mediated by soluble factors released from keratinocytes. Photochem Photobiol 2008; 84(1): 67-68.
38. Berneburg M, Plettenberg H, Krutmann J. Photoaging of human skin. Photodermatol Photoimmunol Photomed 2000; 16(6): 239-244.
39. Barzilai A, Rotman G, Shiloh Y. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair (Amst) 2002; 1(1): 3-25.
40. Trifunovic A, Wredenberg A, Falkenberg M, et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 2004; 429(6990): 417-423.
41. Yasui H, Sakurai H. Age-dependent generation of reactive oxygen species in the skin of live hairless rats exposed to UVA light. Exp Dermatol 2003; 12(5): 655-661.
42. Birch-Machin MA, Tindall M, Turner R, et al. Mitochondrial DNA deletions in human skin reflect photo rather than chronologic aging. J Invest Dermatol 1998; 110(2): 149-152.
43. Berneburg M, Gattermann N, Stege H, et al. Chronically ultraviolet-exposed human skin shows a higher mutation frequency of mitochondrial DNA as compared to unexposed skin and the hematopoietic system. Photochem Photobiol 1997; 66(2): 271-275.
44. Berneburg M, Grether-Beck S, Kurten V, et al. Singlet oxygen mediates the UVA-induced generation of the photoaging-associated mitochondrial common deletion. J Biol Chem 1999; 274(22): 15345-15349.
45. Berneburg M, Plettenberg H, Medve-Konig K, et al. Induction of the photoaging-associated mitochondrial common deletion in vivo in normal human skin. J Invest Dermatol 2004; 122(5): 1277-1283.
46. Berneburg M, Gremmel T, Kurten V, et al. Creatine supplementation normalizes mutagenesis of mitochondrial DNA as well as functional consequences. J Invest Dermatol 2005; 125(2): 213-220.
47. Berneburg M, Trelles M, Friguet B, et al. How best to halt and/or revert UV-induced skin ageing: strategies, facts and fiction. Exp Dermatol 2008; 17(3): 228-240.
48. Edlich RF, Winters KL, Lim HW, et al. Photoprotection by sunscreens with topical antioxidants and systemic antioxidants to reduce sun exposure. J Long Term Eff Med Implants 2004; 14(4): 317-340.
49. Yin L, Morita A, Tsuji T. The crucial role of TGF-beta in the age-related alterations induced by ultraviolet A irradiation. J Invest Dermatol 2003; 120(4): 703-705.
50. Quan TH, He TY, Kang S, et al. Solar ultraviolet irradiation reduces collagen in photoaged human skin by blocking transforming growth factor-beta type II receptor/Smad signaling. Am J Pathol 2004; 165(3): 741-751.
51. Tsoureli-Nikita E, Watson RE, Griffiths CE. Photoageing: the darker side of the sun. Photochem Photobiol Sci 2006; 5(2): 160-164.
52. Saretzki G, Sitte N, Merkel U, et al. Telomere shortening triggers a p53-dependent cell cycle arrest via accumulation of G-rich single stranded DNA fragments. Oncogene 1999; 18(37): 5148-5158.
53. Kosmadaki MG, Gilchrest BA. The role of telomeres in skin aging/photoaging. Micron 2004; 35(3): 155-159.
54. Darlington S, Williams G, Neale R, et al. A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses. Arch Dermatol 2003; 139(4): 451-455.
55. Verschooten L, Claerhout S, Van Laethem A, Agostinis P, Garmyn M. New strategies of photoprotection. Photochem Photobiol 2006; 82(4): 1016-1023.
56. Morison WL. Photoprotection by clothing. Dermatol Ther 2003; 16(1): 16-22.
57. Diffey BL. Sun protection with clothing. Br J Dermatol 2001; 144(3): 449-450.
58. Georgouras KE, Stanford DG, Pailthorpe MT. Sun protective clothing in Australia and the Australian/New Zealand standard: an overview. Australas J Dermatol 1997; 38(suppl 1):S79-S82.
59. CEN-The European Committee for Standardization. Fabrics-solar UV protective propertiesclassification and marking of apparel. Stassart, Brussels: CEN, 1999:PrEN 13758.
60. Lautenschlager S, Wulf HC, Pittelkow MR. Photoprotection. Lancet 2007; 370(9586): 528-537.
61. Laperre J, Gambichler T. Sun protection offered by fabrics: on the relation between effective doses based on different action spectra. Photodermatol Photoimmunol Photomed 2003; 19(1): 11-16.
62. Hatch KL. American standards for UV-protective textiles. Recent Results Cancer Res 2002; 160:42-47.
63. Bestak R, Barnetson RSC, Nearn MR, et al. Sunscreen protection of contact hypersensitivity responses from chronic solar-simulated ultraviolet irradiation correlates with the absorption spectrum of the sunscreen. J Invest Dermatol 1995; 105(3): 345-351.
64. Damian DL, Barnetson RS, Halliday GM. Measurement of in vivo sunscreen immune protection factors in humans. Photochem Photobiol 1999; 70(6): 910-915.
65. Fourtanier A, Moyal D, Maccario J, et al. Measurement of sunscreen immune protection factors in humans: A consensus paper. J Invest Dermatol 2005; 125(3): 403-409.
66. Poon TSC, Barnetson RS, Halliday GM. Prevention of immunosuppression by sunscreens in humans is unrelated to protection from erythema and dependent on protection from ultraviolet A in the face of constant ultraviolet B protection. J Invest Dermatol 2003; 121(1): 184-190.
67. Moyal DD, Fourtanier AM. Broad-spectrum sunscreens provide better protection from the suppression of the elicitation phase of delayed-type hypersensitivity response in humans. J Invest Dermatol 2001; 117(5): 1186-1192.
68. Damian DL, Halliday GM, Barnetson RS. Broad-spectrum sunscreens provide greater protection against ultraviolet-radiation-induced suppression of contact hypersensitivity to a recall antigen in humans. J Invest Dermatol 1997; 109(2): 146-151.
69. Kelly DA, Seed PT, Young AR, et al. A commercial sunscreen’s protection against ultraviolet radiation-induced immunosuppression is more than 50% lower than protection against sunburn in humans. J Invest Dermatol 2003; 120(1): 65-71.
70. Wolf P, Hoffmann C, Quehenberger F, et al. Immune protection factors of chemical sunscreens measured in the local contact hypersensitivity model in humans. J Invest Dermatol 2003; 121(5): 1080-1087.
71. Baron ED, Fourtanier A, Compan D, et al. High ultraviolet A protection affords greater immune protection confirming that ultraviolet A contributes to photoimmunosuppression in humans. J Invest Dermatol 2003; 121(4): 869-875.
72. Reeve VE, Bosnic M, Boehm-Wilcox C, et al. Differential protection by two sunscreens from UV radiation-induced immunosuppression. J Invest Dermatol 1991; 97:624-628.
73. Wolf P, Donawho CK, Kripke ML. Analysis of the protective effect of different sunscreens on ultraviolet radiation-induced local and systemic suppression of contact hypersensitivity and inflammatory responses in mice. J Invest Dermatol 1993; 100(3): 254-259.
74. Nghiem DX, Kazimi N, Clydesdale G, et al. Ultraviolet A radiation suppresses an established immune response: Implications for sunscreen design. J Invest Dermatol 2001; 117(5): 1193-1199.
75. McKinlay AF, Diffey BL. A reference action spectrum for ultraviolet induced erythema in human skin. CIE J 1987; 6:17-22.
76. LeVee GJ, Oberhelman L, Anderson T, et al. UVA II exposure of human skin results in decreased immunization capacity, increased induction of tolerance and a unique pattern of epidermal antigen-presenting cell alteration. Photochem Photobiol 1997; 65(4): 622-629.
77. Kuchel JM, Barnetson RSC, Halliday GM. Ultraviolet A augments solar-simulated ultraviolet radiation-induced local suppression of recall responses in humans. J Invest Dermatol 2002; 118(6): 1032-1037.
78. Byrne SN, Spinks N, Halliday GM. Ultraviolet A irradiation of C57BL/6 mice suppresses systemic contact hypersensitivity or enhances secondary immunity depending on dose. J Invest Dermatol 2002; 119(4): 858-864.
79. Bestak R, Halliday GM. Chronic low-dose UVA irradiation induces local suppression of contact hypersensitivity, Langerhans cell depletion and suppressor cell activation in C3H/HeJ mice. Photochem Photobiol 1996; 64(6): 969-974.
80. Reeve VE, Bosnic M, Boehm-Wilcox C, et al. Ultraviolet A radiation (320-400 nm) protects hairless mice from immunosuppression induced by ultraviolet B radiation (280-320 nm) or cis-urocanic acid. Int Arch Allergy Immunol 1998; 115(4): 316-322.
81. Ho KKL, Halliday GM, Barnetson RS. Sunscreens protect epidermal Langerhans cells and Thy-1þ cells but not local contact sensitization from the effects of ultraviolet light. J Invest Dermatol 1992; 98(5): 720-724.
82. Davenport V, Morris JF, Chu AC. Immunologic protection afforded by sunscreens in vitro. J Invest Dermatol 1997; 108(6): 859-863.
83. Mommaas AM, van Praag MC, Bouwes Bavinck JN, et al. Analysis of the protective effect of topical sunscreens on the UVB-radiation-induced suppression of the mixed-lymphocyte reaction. J Invest Dermatol 1990; 95(3): 313-316.
84. Hurks HMH, Vandermolen RG, Outluiting C, et al. Differential effects of sunscreens on UVBinduced immunomodulation in humans. J Invest Dermatol 1997; 109(6): 699-703.
85. Hofmann-Wellenhof R, Smolle J, Roschger A, et al. Sunburn cell formation, dendritic cell migration, and immunomodulatory factor production after solar-simulated irradiation of sunscreen-treated human skin explants in vitro. J Invest Dermatol 2004; 123(4): 781-787.
86. Haywood R, Wardman P, Sanders R, et al. Sunscreens inadequately protect against ultraviolet-A-induced free radicals in skin: Implications for skin aging and melanoma? J Invest Dermatol 2003; 121(4): 862-868.
87. van der Molen RG, Out-Luiting C, Driller H, et al. Broad-spectrum sunscreens offer protection against urocanic acid photoisomerization by artificial ultraviolet radiation in human skin. J Invest Dermatol 2000; 115(3): 421-426.
88. Olivarius FD, Wulf HC, Crosby J, et al. Sunscreen protection against cis-urocanic acid production in human skin. Acta Derm Venereol 1999; 79(6): 426-430.
89. Kligman LH, Akin FJ, Kligman AM. Prevention of ultraviolet damage to the dermis of hairless mice by sunscreens. J Invest Dermatol 1982; 78(2): 181-189.
90. Kligman LH, Akin FJ, Kligman AM. Sunscreens promote repair of ultraviolet radiationinduced dermal damage. J Invest Dermatol 1983; 81(2): 98-102.
91. Seite S, Colige A, Piquemal-Vivenot P, et al. A full-UV spectrum absorbing daily use cream protects human skin against biological changes occurring in photoaging. Photodermatol Photoimmunol Photomed 2000; 16(4): 147-155.
92. Takeuchi T, Uitto J, Bernstein EF. A novel in vivo model for evaluating agents that protect against ultraviolet A-induced photoaging. J Invest Dermatol 1998; 110(4): 343-347.
93. European Commission’s Recommendation of 22 September 2006 on the efficacy of sunscreen products and the claims made relating thereto. Document C 2006; 4089.
94. Yarosh D, Alas LG, Yee V, et al. Pyrimidine dimer removal enhanced by DNA repair liposomes reduces the incidence of UV skin cancer in mice. Cancer Res 1992; 52(15): 4227-4231.
95. Wolf P, Maier H, Mullegger RR, et al. Topical treatment with liposomes containing T4 endonuclease V protects human skin in vivo from ultraviolet-induced upregulation of interleukin-10 and tumor necrosis factor-alpha. J Invest Dermatol 2000; 114(1): 149-156.
96. Lawrence N. New and emerging treatments for photoaging. Dermatol Clin 2000; 18(1): 99-112.
97. Katiyar SK. UV-induced immune suppression and photocarcinogenesis: chemoprevention by dietary botanical agents. Cancer Lett 2007; 255(1): 1-11.
98. Friedmann AC, Halliday GM, Barnetson RS, et al. The topical isoflavonoid NV-07 alpha reduces solar-simulated UV-induced suppression of Mantoux reactions in humans. Photochem Photobiol 2004; 80(3): 416-421.
99. Middelkamp-Hup MA, Pathak MA, Parrado C, et al. Oral Polypodium leucotomos extract decreases ultraviolet-induced damage of human skin. J Am Acad Dermatol 2004; 51(6): 910-918.
100. Philips N, Smith J, Keller T, et al. Predominant effects of Polypodium leucotomos on membrane integrity, lipid peroxidation, and expression of elastin and matrix metalloproteinase-1 in ultraviolet radiation exposed fibroblasts, and keratinocytes. J Dermatol Sci 2003; 32(1): 1-9.
101. Alcaraz MV, Pathak MA, Rius F, et al. An extract of Polypodium leucotomos appears to minimize certain photoaging changes in a hairless albino mouse animal model. A pilot study. Photodermatol Photoimmunol Photomed 1999; 15(3-4): 120-126.
102. Gonzalez S, Alonso-Lebrero JL, Del Rio R, et al. Polypodium leucotomos extract: a nutraceutical with photoprotective properties. Drugs Today 2007; 43(7): 475-485.
103. Baliga MS, Katiyar SK. Chemoprevention of photocarcinogenesis by selected dietary botanicals. Photochem Photobiol Sci. 2006; 5(2): 243-253.